High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population ; volume:16 ; number:1 ; day:5 ; month:6 ; year:2018 ; pages:1-7 ; date:12.2018
Hereditary cancer in clinical practice ; 16, Heft 1 (5.6.2018), 1-7, 12.2018
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Maksimenko, J.
- Beteiligte Personen und Organisationen
-
Irmejs, A.
Trofimovičs, G.
Bērziņa, D.
Skuja, E.
Purkalne, G.
Miklaševičs, E.
Gardovskis, J.
SpringerLink (Online service)
- DOI
-
10.1186/s13053-018-0094-0
- URN
-
urn:nbn:de:101:1-2018081121403372564122
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maksimenko, J.
- Irmejs, A.
- Trofimovičs, G.
- Bērziņa, D.
- Skuja, E.
- Purkalne, G.
- Miklaševičs, E.
- Gardovskis, J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
The Icelandic founder mutation BRCA2 999del5: analysis of expression
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Chapter V. Founder
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
Islam and its founder
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
The Icelandic founder mutation BRCA2 999del5: analysis of expression
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Chapter V. Founder
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
Islam and its founder
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
The Icelandic founder mutation BRCA2 999del5: analysis of expression
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Chapter V. Founder
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore